RU2409356C2 - Применение амброксола для лечения риновирусных инфекций - Google Patents

Применение амброксола для лечения риновирусных инфекций Download PDF

Info

Publication number
RU2409356C2
RU2409356C2 RU2008110933/15A RU2008110933A RU2409356C2 RU 2409356 C2 RU2409356 C2 RU 2409356C2 RU 2008110933/15 A RU2008110933/15 A RU 2008110933/15A RU 2008110933 A RU2008110933 A RU 2008110933A RU 2409356 C2 RU2409356 C2 RU 2409356C2
Authority
RU
Russia
Prior art keywords
ambroxol
use according
liquid
pharmaceutically acceptable
dosage form
Prior art date
Application number
RU2008110933/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008110933A (ru
Inventor
Анке ЭСПЕРЕСТЕР (DE)
Анке Эсперестер
Лиане ПАУЛЬ (DE)
Лиане ПАУЛЬ
Original Assignee
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Интернациональ Гмбх filed Critical Берингер Ингельхайм Интернациональ Гмбх
Publication of RU2008110933A publication Critical patent/RU2008110933A/ru
Application granted granted Critical
Publication of RU2409356C2 publication Critical patent/RU2409356C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2008110933/15A 2005-08-25 2006-08-03 Применение амброксола для лечения риновирусных инфекций RU2409356C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107792.3 2005-08-25
EP05107792 2005-08-25

Publications (2)

Publication Number Publication Date
RU2008110933A RU2008110933A (ru) 2009-09-27
RU2409356C2 true RU2409356C2 (ru) 2011-01-20

Family

ID=35519889

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008110933/15A RU2409356C2 (ru) 2005-08-25 2006-08-03 Применение амброксола для лечения риновирусных инфекций

Country Status (8)

Country Link
US (1) US20080319087A1 (enExample)
EP (1) EP1928444A2 (enExample)
JP (1) JP2009506002A (enExample)
BR (1) BRPI0614887A2 (enExample)
CA (1) CA2619863A1 (enExample)
MX (1) MX2008002456A (enExample)
RU (1) RU2409356C2 (enExample)
WO (1) WO2007023072A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012123466A1 (de) * 2011-03-14 2012-09-20 Boehringer Ingelheim International Gmbh Verwendung einer sprühfähigen zusammensetzung enthaltend ambroxol
KR101915056B1 (ko) 2012-04-10 2018-11-07 한미약품 주식회사 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법
CN104606170A (zh) * 2015-02-04 2015-05-13 上海华源安徽仁济制药有限公司 一种盐酸氨溴索胶囊及其制备方法
CN105078896A (zh) * 2015-09-22 2015-11-25 青岛华之草医药科技有限公司 一种治疗咳嗽的药物盐酸氨溴索组合物干混悬剂
RU2701737C1 (ru) * 2018-06-28 2019-10-01 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Лекарственное средство для терапии хронических ран
IT201800006909A1 (it) * 2018-07-04 2020-01-04 Polvere secca di ambroxolo per uso inalatorio con target bronchiale
US11013687B1 (en) * 2020-06-08 2021-05-25 Amcyte Pharma, Inc. Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2
WO2021255129A1 (en) * 2020-06-16 2021-12-23 Spedding Research Solutions, Sas Novel use of a modulator of glucosylceramide degradation for viral infections
EP4196154A4 (en) 2020-08-13 2025-01-22 Texas Southern University COMPOSITIONS AND METHODS FOR INHIBITING SARS-COV-2 INFECTION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1437134A1 (en) * 2001-09-04 2004-07-14 Boehringer Ingelheim International GmbH Anti-influenza drugs
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610997A1 (de) * 1986-04-02 1987-10-15 Krewel Werke Gmbh Ambroxol-nasenspray

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1437134A1 (en) * 2001-09-04 2004-07-14 Boehringer Ingelheim International GmbH Anti-influenza drugs
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kido H. et al. Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential. Biol Chem. 2004 Nov; 385(11): 1029-34 (реферат) [он-лайн] [найдено 2010-02-26] Найдено из базы данных PubMed PMID: 15576322. Yang В. et al. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels. Eur Respir J. 2002 May; 19(5):952-8. [он-лайн] [найдено 2010-02-26] Найдено из базы данных PubMed PMID: 12030738. Ottonello L. et al. In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism. Br J Pharmacol. 2003 Oct; 140(4):736-42. [он-лайн] [найдено 2010-02-26] Найдено из базы данных PubMed PMID: 14534155. Энциклопедия лекарств. - M.: РЛС, 2001, с.69-70, 459, 928, 966. *
Руководство по медицине «THE MERCK MANUAL». - M.: Мир, 1997, т.1 с.116-124. *

Also Published As

Publication number Publication date
WO2007023072A2 (en) 2007-03-01
WO2007023072A3 (en) 2007-05-03
BRPI0614887A2 (pt) 2011-04-19
US20080319087A1 (en) 2008-12-25
MX2008002456A (es) 2008-04-07
RU2008110933A (ru) 2009-09-27
JP2009506002A (ja) 2009-02-12
EP1928444A2 (en) 2008-06-11
CA2619863A1 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
US11744895B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
JP5683719B2 (ja) ベポタスチン組成物
JP4365106B2 (ja) 医薬配合剤
US10201519B2 (en) Stabilized pediatric suspension of carisbamate
RU2255736C2 (ru) Фармацевтические композиции, содержащие золмитриптан
JP5759553B2 (ja) ベポタスチン組成物
US11213484B2 (en) Dipivefrin orally disintegrating tablet formulations
RU2409356C2 (ru) Применение амброксола для лечения риновирусных инфекций
CN101460144A (zh) AchE-NMDA组合物干胶片
CA3088989C (en) Intranasal epinephrine formulations and methods for the treatment of disease
EP1503763B1 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
JPH06500537A (ja) アテローム硬化症の治療のためのアリールヒドロキシ尿素化合物の使用
WO2021064589A1 (en) Intranasal pharmaceutical compositions of cyclobenzaprine
BR112019018700A2 (pt) composições farmacêuticas e seus usos
US20250032520A1 (en) Oral cannabinoid compositions and methods for treating neurological diseases and disorders
GB2619970A (en) An orodispersible pharmaceutical composition of baclofen and its process of preparation
WO2025212556A1 (en) Formulations comprising seletracetam and methods of use
KR102027176B1 (ko) 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
HK40121592A (en) Intranasal epinephrine formulations and methods for the treatment of disease
WO2024144678A1 (en) Orally disintegrating tablets (odt) formulations for the treatment of flu, common cold and allergic symptoms
UA47594U (uk) Комбінований засіб для лікування та профілактики захворювань дихальних шляхів
JP2002029973A (ja) 抗ｈｉｖ薬